A high-selectivity FGFR2 inhibitor developed to inhibit FGFR2 phosphorylation, thereby blocking FGFR2 signaling pathways and providing an anti-tumor effect for patients with FGFR2 abnormalities, especially those resistant to other treatments.

A technology platform that combines computational chemistry and AI data analysis to discover potential molecular structures, optimize compounds, predict drug properties, and select targets for drug development.